Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
Circulation
; 119(22): 2877-85, 2009 Jun 09.
Article
em En
| MEDLINE
| ID: mdl-19470889
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirazóis
/
Piridonas
/
Inibidores da Agregação Plaquetária
/
Síndrome Coronariana Aguda
Tipo de estudo:
Clinical_trials
/
Guideline
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Circulation
Ano de publicação:
2009
Tipo de documento:
Article